Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
Data(s) |
2010
|
---|---|
Resumo |
Rationale: Peroxisome proliferator activated receptor (PPAR)-beta/delta is a transcription factor that belongs to the PPAR nuclear hormone receptor family, but the role of PPAR-beta/delta in sepsis is unknown. Objectives: We investigated the role of PPAR-beta/delta in murine models of LPS-induced organ injury and dysfunction and cecal ligation and puncture (CLP)-induced polymicrobial sepsis. Methods: Wild-type (WT) and PPAR-beta/delta knockout (1(0) mice and C57BL/6 mice were subjected to LPS for 16 hours. C57BL/6 mice received the PPAR-beta/delta agonist GW0742 (0.03 mg/kg intravenously, 1 h after LPS) or GW0742 plus the PPAR-beta/delta antagonist GSK0660 (0.1 mg/kg intravenously, 30 min before LPS). CD-1 mice subjected to CLP received GW0742 or GW0742 plus GSK0660. Measurements and Main Results: In PPAR-beta/delta KO mice, endotoxemia exacerbated organ injury and dysfunction (cardiac, renal, and hepatic) and inflammation (lung) compared with WT mice. In C57BL/6 mice subjected to endotoxemia, GW0742 significantly (1) attenuated organ (cardiac and renal) dysfunction and inflammation (lung); (2) increased the phosphorylation of Akt and glycogen synthase kinase (GSK)-3 beta; (3) attenuated the increase in extracellular signal-regulated kinase (ERK)1/2 and signal transducer and activator of transcription (STAT)-3 phosphorylation; and (4) attenuated the activation of nuclear factor (NF)-kappa B and the expression of inducible nitric oxide synthase (iNOS). In CD-1 mice subjected to CLP, GW0742 improved 10-day survival. All the observed beneficial effects of GW0742 were attenuated by the PPAR-beta/delta antagonist GSK0660. Conclusions: PPAR-beta/delta protects against multiple organ injury and dysfunction, and inflammation caused by endotoxic shock and improves survival in polymicrobial sepsis by a mechanism that may involve activation of Akt and inhibition of GSK-3 beta and NF-kappa B. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_0E71863AACE2 isbn:1535-4970[electronic], 1073-449X[linking] pmid:20693380 doi:10.1164/rccm.201002-0240OC isiid:000285534600010 |
Idioma(s) |
en |
Fonte |
American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1506-1515 |
Palavras-Chave | #Animals; Disease Models, Animal; Glycogen Synthase Kinase 3/metabolism; Male; Mice; Mice, Inbred C57BL; NF-kappa B/metabolism; Nitric Oxide Synthase Type II/biosynthesis; PPAR delta/metabolism; PPAR-beta/metabolism; Phosphorylation/drug effects; Proto-Oncogene Proteins c-akt/metabolism; Shock, Septic/metabolism; Shock, Septic/prevention & control; Signal Transduction; Sulfones/pharmacology; Thiazoles/pharmacology; Thiophenes/pharmacology |
Tipo |
info:eu-repo/semantics/article article |